Werewolf Therapeutics, Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Dec 2019 | — | $-24.3M | $18.1M |
| Mar 2020 | — | $-28.1M | $14.3M |
| Jun 2020 | — | $-25.6M | $32.0M |
| Sep 2020 | — | $-31.6M | $26.9M |
| Dec 2020 | — | $-51.9M | $92.6M |
| Mar 2021 | — | $-153.8M | $84.6M |
| Jun 2021 | — | $181.6M | $183.2M |
| Sep 2021 | — | $169.3M | $170.4M |
| Dec 2021 | — | $152.8M | $157.5M |
| Mar 2022 | — | $139.3M | $143.7M |
| Jun 2022 | — | $129.8M | $145.7M |
| Sep 2022 | — | $130.9M | $140.5M |
| Dec 2022 | — | $122.3M | $129.3M |
| Mar 2023 | — | $121.1M | $147.9M |
| Jun 2023 | — | $118.6M | $137.5M |
| Sep 2023 | — | $112.4M | $130.1M |
| Dec 2023 | $40.0M | $111.4M | $134.3M |
| Mar 2024 | $40.0M | $117.6M | $139.2M |
| Jun 2024 | $32.1M | $104.0M | $135.3M |
| Sep 2024 | $32.1M | $89.4M | $122.8M |
| Dec 2024 | $32.1M | $73.4M | $111.0M |
| Mar 2025 | $32.1M | $57.3M | $92.0M |
| Jun 2025 | $32.1M | $41.5M | $77.6M |
| Sep 2025 | $32.1M | $29.6M | $65.7M |
| Dec 2025 | $32.1M | $24.8M | $57.1M |
| Mar 2026 | $32.1M | $12.2M | $46.5M |
| Jun 2026 | — | $16.3M | $22.0M |